Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

Researchers analyzed mulitomic and clinical data from 2000 colorectal cancer samples and used an AI tool, iPhenMap, to help identify cancer cell vulnerabilities and drug combinations that could be used to treat MSS CRC. The post Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities appeared first on GEN - Genetic Engineering and Biotechnology News .

genengnews.com ·7h ago

We haven't written up this one. GEN Biotechnology has the full story — the link below goes straight to it.

Read the original at genengnews.com →

Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

More in Health & Medicine

A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study

KFSH Advances Gene Therapy for Sickle Cell Disease Using Patients’ Own Modified Stem Cells

Moderna and Merck say their mRNA cancer vaccine cut death, recurrence by 42%

Study finds patients experienced rapid weight gain after starting antipsychotic medication

mRNA Melanoma Vaccine Cuts Risk of Recurrence or Death, Leaked Trial Data Show

United, Humana Medicare Advantage Plan Cuts Expected to Hit 1M Americans